Anaptys Announces Participation in Upcoming Investor Conferences

SAN DIEGO, Nov. 10, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a company focused on managing the financial collaborations for Jemperli with Tesaro, a GSK company, and Quimilza (imsidolimab) with Vanda, today announced that members of its executive team are scheduled to participate in multiple upcoming investor conferences:

UBS Global Biopharma Conference 2026, London * Format – Fireside chat * Date and Time – Tuesday, November 17, 2026 at 4:40pm GMT / 11:40am ET * Participant – Daniel Faga, president and chief executive officer Piper Sandler 38(th) Annual Healthcare Conference, New York * Format – Fireside chat and one-on-one investor meetings * Date and Time – Wednesday, December 2, 2026 at 8:00am ET * Participant – Chris Murphy, chief financial officer 9(th) Annual Evercore Healthcare Conference, Miami * Format – Fireside chat * Date and Time – Wednesday, December 2, 2026 at 10:50am ET * Participant – Daniel Faga, president and chief executive officer Live webcasts of the fireside chats will be available on the investor section of the Anaptys website at https://ir.anaptysbio.com/presentations-and-events. Replays of the webcasts will be available for at least 30 days following the events.